Efficacy, safety and tolerability of XM17 compared to Gonal-f in women undergoing assisted reproductive technologies: a multinational, multicentre, randomised, controlled, assessor-blind, parallel group phase III study including follow-up periods.

Trial Profile

Efficacy, safety and tolerability of XM17 compared to Gonal-f in women undergoing assisted reproductive technologies: a multinational, multicentre, randomised, controlled, assessor-blind, parallel group phase III study including follow-up periods.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2014

At a glance

  • Drugs Follitropin alfa (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Sponsors BioGeneriX
  • Most Recent Events

    • 16 Aug 2014 Status changed from recruiting to completed as reported by EudraCT record.
    • 24 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top